Vogt-Koyanagi-Harada Disease: Clinical Outcomes
Authors:
- Jennifer E. ThorneJTJennifer E. Thorne
- John H. KempenJKJohn H. Kempen
- James P. DunnJDJames P. Dunn
- Douglas A. JabsDJDouglas A. Jabs
- 1 October 2005
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 140 (4) , 674.e1-674.e6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Complications and prognostic factors in Vogt-Koyanagi-Harada diseaseAmerican Journal of Ophthalmology, 2001
- Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclatureAmerican Journal of Ophthalmology, 2001
- Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAmerican Journal of Ophthalmology, 2000
- Subretinal fibrosis in patients with Vogt-Koyanagi-Harada DiseaseOphthalmology, 2000
- Vogt-Koyanagi-Harada syndromeSurvey of Ophthalmology, 1995
- Incidence and Management of Cataracts in Vogt-Koyanagi-Harada SyndromeAmerican Journal of Ophthalmology, 1994
- Incidence and Management of Glaucoma in Vogt-Koyanagi-Harada SyndromeOphthalmology, 1993
- Vogt-Koyanagi-Harada SyndromeArchives of Ophthalmology (1950), 1991
- Cyclosporin a Therapy in the Treatment of Intraocular Inflammatory Disease Resistant to Systemic Corticosteroids and Cytotoxic AgentsAmerican Journal of Ophthalmology, 1983
- Vogt–Koyanagi–Harada SyndromeAmerican Journal of Ophthalmology, 1980